{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:39:24Z","timestamp":1789706364954,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T00:00:00Z","timestamp":1397088000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Clinical management of malignant pleural mesothelioma (MPM) is very challenging because of the uncommon resistance of this tumor to chemotherapy. We report here increased expression of macrophage colony-stimulating-factor-1-receptor (M-CSF\/CSF-1R) mRNA in mesothelioma <jats:italic>versus<\/jats:italic> normal tissue specimens and demonstrate that CSF-1R expression identifies chemoresistant cells of mesothelial nature in both primary cultures and mesothelioma cell lines. By using RNAi or ligand trapping, we demonstrate that the chemoresistance properties of those cells depend on autocrine CSF-1R signaling. At the single-cell level, the isolated CSF-1R<jats:sup>pos<\/jats:sup> cells exhibit a complex repertoire of pluripotency, epithelial\u2013mesenchymal transition and detoxifying factors, which define a clonogenic, chemoresistant, precursor-like cell sub-population. The simple activation of CSF-1R in untransformed mesothelial cells is sufficient to confer clonogenicity and resistance to pemetrexed, hallmarks of mesothelioma. In addition, this induced a gene expression profile highly mimicking that observed in the MPM cells endogenously expressing the receptor and the ligands, suggesting that CSF-1R expression is mainly responsible for the phenotype of the identified cell sub-populations. The survival of CSF1R<jats:sup>pos<\/jats:sup> cells requires active AKT (v-akt murine thymoma viral oncogene homolog 1) signaling, which contributed to increased levels of nuclear, transcriptionally competent <jats:italic>\u03b2<\/jats:italic>-catenin. Inhibition of AKT reduced the transcriptional activity of <jats:italic>\u03b2<\/jats:italic>-catenin-dependent reporters and sensitized the cells to senescence-induced clonogenic death after pemetrexed treatment. This work expands what is known on the non-macrophage functions of CSF-1R and its role in solid tumors, and suggests that CSF-1R signaling may have a critical pathogenic role in a prototypical, inflammation-related cancer such as MPM and therefore may represent a promising target for therapeutic intervention.<\/jats:p>","DOI":"10.1038\/cddis.2014.136","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T14:34:15Z","timestamp":1397140455000},"page":"e1167-e1167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Autocrine CSF-1R signaling drives mesothelioma chemoresistance via AKT activation"],"prefix":"10.1038","volume":"5","author":[{"given":"M","family":"Cioce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Canino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Goparaju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H I","family":"Pass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,10]]},"reference":[{"key":"BFcddis2014136_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V","volume":"46","author":"ER Stanley","year":"1997","unstructured":"Stanley ER, Berg KL, Einstein DB, Lee PS, Pixley FJ, Wang Y et al. Biology and action of colony-stimulating factor-1. Mol Reprod Dev 1997; 46: 4\u201310.","journal-title":"Mol Reprod Dev"},{"key":"BFcddis2014136_CR2","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1189\/jlb.1209780","volume":"87","author":"N Droin","year":"2010","unstructured":"Droin N, Solary E . Editorial: CSF1R, CSF-1, and IL-34, a \u2018menage a trois\u2019 conserved across vertebrates. J Leukocyte Biol 2010; 87: 745\u2013747.","journal-title":"J Leukocyte Biol"},{"key":"BFcddis2014136_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3109\/10408363.2012.666845","volume":"49","author":"KA Mouchemore","year":"2012","unstructured":"Mouchemore KA, Pixley FJ . CSF-1 signaling in macrophages: pleiotrophy through phosphotyrosine-based signaling pathways. Crit Rev Clin Lab Sci 2012; 49: 49\u201361.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"BFcddis2014136_CR4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0092-8674(85)80047-7","volume":"41","author":"CJ Sherr","year":"1985","unstructured":"Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER . The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 1985; 41: 665\u2013676.","journal-title":"Cell"},{"key":"BFcddis2014136_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1083\/jcb.200309102","volume":"165","author":"CN Wrobel","year":"2004","unstructured":"Wrobel CN, Debnath J, Lin E, Beausoleil S, Roussel MF, Brugge JS . Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture. J Cell Biol 2004; 165: 263\u2013273.","journal-title":"J Cell Biol"},{"key":"BFcddis2014136_CR6","doi-asserted-by":"publisher","first-page":"e13587","DOI":"10.1371\/journal.pone.0013587","volume":"5","author":"ML Knowlton","year":"2010","unstructured":"Knowlton ML, Selfors LM, Wrobel CN, Gu TL, Ballif BA, Gygi SP et al. Profiling Y561-dependent and -independent substrates of CSF-1R in epithelial cells. PLoS One 2010; 5: e13587.","journal-title":"PLoS One"},{"key":"BFcddis2014136_CR7","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/1097-0142(19910215)67:4<990::AID-CNCR2820670422>3.0.CO;2-8","volume":"67","author":"G Baiocchi","year":"1991","unstructured":"Baiocchi G, Kavanagh JJ, Talpaz M, Wharton JT, Gutterman JU, Kurzrock R . Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies. Cancer 1991; 67: 990\u2013996.","journal-title":"Cancer"},{"key":"BFcddis2014136_CR8","doi-asserted-by":"publisher","first-page":"14404","DOI":"10.1073\/pnas.222537099","volume":"99","author":"H Ide","year":"2002","unstructured":"Ide H, Seligson DB, Memarzadeh S, Xin L, Horvath S, Dubey P et al. Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression. Proc Natl Acad Sci USA 2002; 99: 14404\u201314409.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2014136_CR9","first-page":"285","volume":"107","author":"B Kascinski","year":"2002","unstructured":"Kascinski B . Expression of CSF-1 and its receptor CSF-1R in non-hematopoietic neoplasms. Cancer Treat Res 2002; 107: 285\u2013292.","journal-title":"Cancer Treat Res"},{"key":"BFcddis2014136_CR10","first-page":"999","volume":"3","author":"SK Chambers","year":"1997","unstructured":"Chambers SK, Kacinski BM, Ivins CM, Carcangiu ML . Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1. Clin Cancer Res 1997; 3: 999\u20131007.","journal-title":"Clin Cancer Res"},{"key":"BFcddis2014136_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1158\/0008-5472.CAN-11-1232","volume":"72","author":"J Menke","year":"2012","unstructured":"Menke J, Kriegsmann J, Schimanski CC, Schwartz MM, Schwarting A, Kelley VR . Autocrine CSF-1 and CSF-1 receptor coexpression promotes renal cell carcinoma growth. Cancer Res 2012; 72: 187\u2013200.","journal-title":"Cancer Res"},{"key":"BFcddis2014136_CR12","doi-asserted-by":"publisher","first-page":"9498","DOI":"10.1158\/0008-5472.CAN-09-1868","volume":"69","author":"A Patsialou","year":"2009","unstructured":"Patsialou A, Wyckoff J, Wang Y, Goswami S, Stanley ER, Condeelis JS . Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor. Cancer Res 2009; 69: 9498\u20139506.","journal-title":"Cancer Res"},{"key":"BFcddis2014136_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/jcp.22724","volume":"227","author":"M Carbone","year":"2012","unstructured":"Carbone M, Ly BH, Dodson RF, Pagano I, Morris PT, Dogan UA et al. Malignant mesothelioma: facts, myths, and hypotheses. J Cell Physiol 2012; 227: 44\u201358.","journal-title":"J Cell Physiol"},{"key":"BFcddis2014136_CR14","first-page":"508","volume":"1","author":"AK Nowak","year":"2012","unstructured":"Nowak AK . Chemotherapy for malignant pleural mesothelioma: a review of current management and a look to the future. Ann Cardiothorac Surg 2012; 1: 508\u2013515.","journal-title":"Ann Cardiothorac Surg"},{"key":"BFcddis2014136_CR15","first-page":"389","volume":"151","author":"YM Janssen","year":"1997","unstructured":"Janssen YM, Driscoll KE, Howard B, Quinlan TR, Treadwell M, Barchowsky A et al. Asbestos causes translocation of p65 protein and increases NF-kappa B DNA binding activity in rat lung epithelial and pleural mesothelial cells. Am J Pathol 1997; 151: 389\u2013401.","journal-title":"Am J Pathol"},{"key":"BFcddis2014136_CR16","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1158\/1078-0432.CCR-11-2259","volume":"18","author":"M Carbone","year":"2012","unstructured":"Carbone M, Yang H . Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma. Clin Cancer Res 2012; 18: 598\u2013604.","journal-title":"Clin Cancer Res"},{"key":"BFcddis2014136_CR17","doi-asserted-by":"publisher","first-page":"12611","DOI":"10.1073\/pnas.1006542107","volume":"107","author":"H Yang","year":"2010","unstructured":"Yang H, Rivera Z, Jube S, Nasu M, Bertino P, Goparaju C et al. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proc Natl Acad Sci USA 2010; 107: 12611\u201312616.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2014136_CR18","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1053\/S0046-8177(03)00339-3","volume":"34","author":"A Lugli","year":"2003","unstructured":"Lugli A, Forster Y, Haas P, Nocito A, Bucher C, Bissig H et al. Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samples. Hum Pathol 2003; 34: 994\u20131000.","journal-title":"Hum Pathol"},{"key":"BFcddis2014136_CR19","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1126\/science.1154370","volume":"320","author":"H Lin","year":"2008","unstructured":"Lin H, Lee E, Hestir K, Leo C, Huang M, Bosch E et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 2008; 320: 807\u2013811.","journal-title":"Science"},{"key":"BFcddis2014136_CR20","first-page":"63","volume":"4","author":"BL Abbott","year":"2006","unstructured":"Abbott BL . ABCG2 (BCRP): a cytoprotectant in normal and malignant stem cells. Clin Adv Hematol Oncol 2006; 4: 63\u201372.","journal-title":"Clin Adv Hematol Oncol"},{"key":"BFcddis2014136_CR21","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.bcp.2012.01.002","volume":"83","author":"K Natarajan","year":"2012","unstructured":"Natarajan K, Xie Y, Baer MR, Ross DD . Role of breast cancer resistance protein (BCRP\/ABCG2) in cancer drug resistance. Biochem Pharmacol 2012; 83: 1084\u20131103.","journal-title":"Biochem Pharmacol"},{"key":"BFcddis2014136_CR22","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s00296-010-1688-7","volume":"31","author":"H Eda","year":"2011","unstructured":"Eda H, Shimada H, Beidler DR, Monahan JB . Proinflammatory cytokines, IL-1beta and TNF-alpha, induce expression of interleukin-34 mRNA via JNK- and p44\/42 MAPK-NF-kappaB pathway but not p38 pathway in osteoblasts. Rheumatol Int 2011; 31: 1525\u20131530.","journal-title":"Rheumatol Int"},{"key":"BFcddis2014136_CR23","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.4161\/cc.10.9.15486","volume":"10","author":"P Marcato","year":"2011","unstructured":"Marcato P, Dean CA, Giacomantonio CA, Lee PW . Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform. Cell Cycle 2011; 10: 1378\u20131384.","journal-title":"Cell Cycle"},{"key":"BFcddis2014136_CR24","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1073\/pnas.0808300106","volume":"106","author":"TC Chang","year":"2009","unstructured":"Chang TC, Zeitels LR, Hwang HW, Chivukula RR, Wentzel EA, Dews M et al. Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc Natl Acad Sci USA 2009; 106: 3384\u20133389.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"BFcddis2014136_CR25","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/fcp.12043","volume":"28","author":"Marzieh Badinloo","year":"2013","unstructured":"Badinloo M, Esmaeili-Mahani S . Phosphatidylinositol 3-kinases inhibitor LY294002 potentiates the cytotoxic effects of doxorubicin, vincristine, and etoposide in a panel of cancer cell lines. Fundam Clin Pharmacol 2013; e-pub ahead of print 17 June 2013; doi:10.1111\/fcp.12043.","journal-title":"Fundamental & Clinical Pharmacology"},{"key":"BFcddis2014136_CR26","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4161\/cc.11.1.18474","volume":"11","author":"M Cioce","year":"2012","unstructured":"Cioce M, Canino C, Pulito C, Muti P, Strano S, Blandino G . Butein impairs the protumorigenic activity of malignant pleural mesothelioma cells. Cell Cycle 2012; 11: 132\u2013140.","journal-title":"Cell Cycle"},{"key":"BFcddis2014136_CR27","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s11605-012-1913-7","volume":"16","author":"BK Holcomb","year":"2012","unstructured":"Holcomb BK, Yip-Schneider MT, Waters JA, Beane JD, Crooks PA, Schmidt CM . Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells. J Gastrointest Surg 2012; 16: 1333\u20131340.","journal-title":"J Gastrointest Surg"},{"key":"BFcddis2014136_CR28","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/1476-4598-9-314","volume":"9","author":"A Shukla","year":"2010","unstructured":"Shukla A, Hillegass JM, MacPherson MB, Beuschel SL, Vacek PM, Pass HI et al. Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin. Mol Cancer 2010; 9: 314.","journal-title":"Mol Cancer"},{"key":"BFcddis2014136_CR29","first-page":"211","volume":"17","author":"CW Rettenmier","year":"1986","unstructured":"Rettenmier CW, Roussel MF, Wheeler EF, Sherr CJ . Requirements for transformation by the fms oncogene product (CSF-1 receptor). Princess Takamatsu Symp 1986; 17: 211\u2013218.","journal-title":"Princess Takamatsu Symp"},{"key":"BFcddis2014136_CR30","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/0092-8674(88)90243-7","volume":"55","author":"MF Roussel","year":"1988","unstructured":"Roussel MF, Downing JR, Rettenmier CW, Sherr CJ . A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential. Cell 1988; 55: 979\u2013988.","journal-title":"Cell"},{"issue":"Suppl 2","key":"BFcddis2014136_CR31","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1517\/14728222.2011.639361","volume":"16","author":"A De Luca","year":"2012","unstructured":"De Luca A, Maiello MR, D'Alessio A, Pergameno M, Normanno N . The RAS\/RAF\/MEK\/ERK and the PI3K\/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches. Expert Opin Therap Targets 2012; 16 (Suppl 2): S17\u2013S27.","journal-title":"Expert Opin Therap Targets"},{"key":"BFcddis2014136_CR32","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers H, Nusse R . Wnt\/beta-catenin signaling and disease. Cell 2012; 149: 1192\u20131205.","journal-title":"Cell"},{"key":"BFcddis2014136_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/sj.onc.1206097","volume":"22","author":"M Bocchetta","year":"2003","unstructured":"Bocchetta M, Miele L, Pass HI, Carbone M . Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells. Oncogene 2003; 22: 81\u201389.","journal-title":"Oncogene"},{"key":"BFcddis2014136_CR34","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1158\/1078-0432.CCR-12-1045","volume":"19","author":"AJ Ziebarth","year":"2013","unstructured":"Ziebarth AJ, Nowsheen S, Steg AD, Shah MM, Katre AA, Dobbin ZC et al. Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer. Clin Cancer Res 2013; 19: 170\u2013182.","journal-title":"Clin Cancer Res"},{"key":"BFcddis2014136_CR35","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/ni.1744","volume":"10","author":"K Otero","year":"2009","unstructured":"Otero K, Turnbull IR, Poliani PL, Vermi W, Cerutti E, Aoshi T et al. Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin. Nat Immunol 2009; 10: 734\u2013743.","journal-title":"Nat Immunol"},{"key":"BFcddis2014136_CR36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1476-4598-9-97","volume":"9","author":"SS Han","year":"2010","unstructured":"Han SS, Yun H, Son DJ, Tompkins VS, Peng L, Chung ST et al. NF-kappaB\/STAT3\/PI3K signaling crosstalk in iMyc E mu B lymphoma. Mol Cancer 2010; 9: 97.","journal-title":"Mol Cancer"},{"key":"BFcddis2014136_CR37","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.canlet.2011.01.009","volume":"302","author":"C Casarsa","year":"2011","unstructured":"Casarsa C, Bassani N, Ambrogi F, Zabucchi G, Boracchi P, Biganzoli E et al. Epithelial-to-mesenchymal transition, cell polarity and stemness-associated features in malignant pleural mesothelioma. Cancer Lett 2011; 302: 136\u2013143.","journal-title":"Cancer Lett"},{"key":"BFcddis2014136_CR38","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.athoracsur.2013.01.012","volume":"95","author":"M Kobayashi","year":"2013","unstructured":"Kobayashi M, Huang CL, Sonobe M, Kikuchi R, Ishikawa M, Imamura N et al. Snail expression is associated with a poor prognosis in malignant pleural mesotheliomas. Ann Thorac Surg 2013; 95: 1181\u20131188.","journal-title":"Ann Thorac Surg"},{"key":"BFcddis2014136_CR39","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/0003-4975(95)00045-M","volume":"59","author":"HI Pass","year":"1995","unstructured":"Pass HI, Stevens EJ, Oie H, Tsokos MG, Abati AD, Fetsch PA et al. Characteristics of nine newly derived mesothelioma cell lines. Ann Thorac Surg 1995; 59: 835\u2013844.","journal-title":"Ann Thorac Surg"},{"key":"BFcddis2014136_CR40","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1128\/MCB.20.4.1436-1447.2000","volume":"20","author":"MA Dickson","year":"2000","unstructured":"Dickson MA, Hahn WC, Ino Y, Ronfard V, Wu JY, Weinberg RA et al. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 2000; 20: 1436\u20131447.","journal-title":"Mol Cell Biol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cddis2014136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cddis2014136","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2014136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T23:26:37Z","timestamp":1672961197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2014136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,10]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4]]}},"alternative-id":["BFcddis2014136"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2014.136","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,10]]},"assertion":[{"value":"31 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}